H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 15.9% of adults in Corpus Christi have diagnosed diabetes — 3.9 points above the U.S. 12% figure. Census population 317,863. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Corpus Christi clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Corpus Christi storefront.
Non-Surgical Regenerative Therapy Options in Corpus Christi, TX for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
Adult obesity in Corpus Christi is 39.7% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 15.9% of adults in Corpus Christi have diagnosed diabetes — 3.9 points above the U.S. 12% figure. Texas includes CDC Diabetes Belt counties, so DFU planning belongs in the annual budget. Hawk Medical is the distributor for non surgical regenerative therapy, not a walk-in clinic.
National Non-Surgical Regenerative Therapy Options notes (how the product actually works)JH reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Corpus Christi is 15.9% or not. PLACES is planning data. The LCD is the claim.
If you already buy non surgical regenerative therapy elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 15.9% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 15.9% of adults — 3.9 points above the U.S. 12% figure. Obesity is 39.7%; arthritis is 22%. That is place-level BRFSS modeling, not a clinic census and not a Corpus Christi trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Texas.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Corpus Christi tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Corpus Christi, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Corpus Christi is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Corpus Christi — 3.9 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Corpus Christi. Useful for joint-program math; still needs a diagnosis and privileging.
No Corpus Christi storefront. Joe Bradley is an active practice owner. non surgical regenerative therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.